Nanomaterial-based therapeutics for enhanced antifungal therapy

Area of Science:

• Mycology
• Nanotechnology
• Pharmacology

Background:

• Current antifungal drugs face significant challenges including severe side effects, low bioavailability, and emerging resistance.
• These limitations hinder effective treatment of fungal infections, necessitating innovative therapeutic strategies.

Purpose of the Study:

• To review the application of nanotechnology in antifungal therapy.
• To discuss strategies for enhancing antifungal efficacy using nanomaterials.
• To explore emerging nanomaterial-based approaches for treating fungal infections.

Main Methods:

• Review of scientific literature on nanotechnology applications in antifungal therapy.
• Discussion of three key strategies: surface tailoring of nanomaterials, stimuli-responsive drug release, and barrier penetration.
• Exploration of novel strategies like fungal vaccines and macrophage modulation.

Main Results:

• Nanomaterials can improve antifungal efficacy through enhanced interaction with fungal cells via surface tailoring.
• Stimuli-responsive nanomaterials enable smart drug release in pathological microenvironments, such as fungal biofilms.
• Nanomaterials can be designed to overcome physiological barriers (skin, corneal, blood-brain), improving drug delivery.

Conclusions:

• Nanotechnology presents a promising avenue for overcoming limitations in current antifungal therapies.
• Innovative nanomaterial-based strategies offer potential for improved treatment of fungal infections.
• Despite challenges, nanotechnology holds significant potential for future clinical applications in antifungal therapy.